Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Doping in sport: effects, harm and misconceptions.
Birzniece V. Birzniece V. Intern Med J. 2015 Mar;45(3):239-48. doi: 10.1111/imj.12629. Intern Med J. 2015. PMID: 25369881 Review.
Effects of raloxifene and estrogen on bioactive IGF1 in GH-deficient women.
Birzniece V, Magnusson NE, Ho KK, Frystyk J. Birzniece V, et al. Eur J Endocrinol. 2014 Feb 4;170(3):375-83. doi: 10.1530/EJE-13-0835. Print 2014 Mar. Eur J Endocrinol. 2014. PMID: 24347426 Clinical Trial.
Plasma biomarker proteins for detection of human growth hormone administration in athletes.
Tan SH, Lee A, Pascovici D, Care N, Birzniece V, Ho K, Molloy MP, Khan A. Tan SH, et al. Among authors: birzniece v. Sci Rep. 2017 Aug 30;7(1):10039. doi: 10.1038/s41598-017-09968-7. Sci Rep. 2017. PMID: 28855568 Free PMC article. Clinical Trial.
Decorin, a growth hormone-regulated protein in humans.
Bahl N, Stone G, McLean M, Ho KKY, Birzniece V. Bahl N, et al. Among authors: birzniece v. Eur J Endocrinol. 2018 Feb;178(2):145-152. doi: 10.1530/EJE-17-0844. Epub 2017 Nov 14. Eur J Endocrinol. 2018. PMID: 29138241 Clinical Trial.
Hepatic actions of androgens in the regulation of metabolism.
Birzniece V. Birzniece V. Curr Opin Endocrinol Diabetes Obes. 2018 Jun;25(3):201-208. doi: 10.1097/MED.0000000000000405. Curr Opin Endocrinol Diabetes Obes. 2018. PMID: 29373481 Review.
Tamoxifen reduces hepatic VLDL production and GH secretion in women: a possible mechanism for steatosis development.
Birzniece V, Barrett PHR, Ho KKY. Birzniece V, et al. Eur J Endocrinol. 2017 Aug;177(2):137-143. doi: 10.1530/EJE-17-0151. Epub 2017 May 12. Eur J Endocrinol. 2017. PMID: 28500244 Free article. Clinical Trial.
Sex steroids and the GH axis: Implications for the management of hypopituitarism.
Birzniece V, Ho KKY. Birzniece V, et al. Best Pract Res Clin Endocrinol Metab. 2017 Feb;31(1):59-69. doi: 10.1016/j.beem.2017.03.003. Epub 2017 Mar 14. Best Pract Res Clin Endocrinol Metab. 2017. PMID: 28477733 Review.
Estrogen receptor antagonism uncovers gender-dimorphic suppression of whole body fat oxidation in humans: differential effects of tamoxifen on the GH and gonadal axes.
Birzniece V, Ho KK. Birzniece V, et al. Eur J Endocrinol. 2015 Oct;173(4):479-87. doi: 10.1530/EJE-15-0426. Epub 2015 Jul 21. Eur J Endocrinol. 2015. PMID: 26199431
Oral low-dose testosterone administration induces whole-body protein anabolism in postmenopausal women: a novel liver-targeted therapy.
Birzniece V, Umpleby MA, Poljak A, Handelsman DJ, Ho KK. Birzniece V, et al. Eur J Endocrinol. 2013 Jul 29;169(3):321-7. doi: 10.1530/EJE-13-0406. Print 2013 Sep. Eur J Endocrinol. 2013. PMID: 23832866 Clinical Trial.
Gender difference in the neuroendocrine regulation of growth hormone axis by selective estrogen receptor modulators.
Birzniece V, Sutanto S, Ho KK. Birzniece V, et al. J Clin Endocrinol Metab. 2012 Apr;97(4):E521-7. doi: 10.1210/jc.2011-3347. Epub 2012 Feb 8. J Clin Endocrinol Metab. 2012. PMID: 22319035 Clinical Trial.
39 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback